Autres langues Sysmex Corporation

Actions

6869

JP3351100007

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 16/05/2024			Varia. 5j.	Varia. 1 janv.
2 696 ^JPY	+0,07 %		+1,51 %	+2,91 %

13/02	Sysmex va procéder à un fractionnement d'actions à raison de 3 pour 1 ; les actions bondissent de 4%.	MT
09/02	Sysmex Corporation annonce ses résultats pour les neuf mois se terminant le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sysmex : Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2024	09/05
Sysmex : Notice Regarding the Booking of a Loss on Valuation of Shares of Subsidiaries and Associates and a Provision for Loss on Guarantees (Non-Consolidated Financial Statements)	09/05
Sysmex : Announcement of Executive Change	09/05
Sysmex : Medicaroid Receives MHLW Approval for the Use of the hinotori™ Surgical Robot System in Thoracic Surgery (Medicaroid)	17/04
Sysmex : Announcement of Organizational and Personnel Changes	07/03
Sysmex to Carry Out 3-for-1 Stock Split; Shares Jump 4%	13/02
Sysmex Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023	09/02
Sysmex Corporation Reaffirm Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	09/02
Cellavision, Sysmex Expand Hematology Partnership Deal	06/02
CellaVision and Sysmex Sign Strategic Alliance Agreement	06/02
CellaVision and Sysmex Corporation Sign Strategic Alliance Agreement	06/02
Germany’s USU Software Signs Knowledge Management Deal with Japan’s Sysmex	16/01
Sysmex : Expands Sales of Its Reagents for Blood-based Amyloid β Testing to Europe	25/12
Sysmex Corporation acquired additional unknown stake in Megakaryon Corporation.	21/12
Fujirebio and Sysmex sign agreement for the supply of reagent raw materials in the field of Immunoassay	15/12
Fujirebio Holdings, Inc. and Sysmex Corporation Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay	14/12
Sysmex : to Reinforce IVD Instrument Production to Support Total Solutions in Clinical Testing- Expansion of Subsidiary's Manufacturing Factory Ensures Stable Global Supply and Enhanced Laboratory Productivity	05/12
VCCT Inc announced that it has received ¥600 million in funding from YASKAWA Electric Corporation, Dai-Dan Co., Ltd., Sysmex Corporation	15/11
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary	03/11
Neue Käufe im Asien-Portfolio von MarketScreener	25/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sysmex Corporation

Actions

6869

JP3351100007

Autres langues

Filtres